Dermatologic Infections In Cancer Patients Treated With EGFRI Therapy
Patients who experience dermatologic toxic effects from epidermal growth factor receptor inhibitors (EGFRIs) have a high prevalence of skin and nail infections, according to a new study published online December 9 in the Journal of the National Cancer Institute…
Also tagged Cancer Patients, Cancer Therapy, Growth Factor Receptor, Journal Of The National Cancer Institute, National Cancer Institute, Prevalence, Skin Infections, Toxic Effects
